Insider Selling: SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells 3,670 Shares of Stock

SI-BONE, Inc. (NASDAQ:SIBN) insider Anthony J. Recupero sold 3,670 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $13.90, for a total transaction of $51,013.00. Following the completion of the transaction, the insider now owns 222,814 shares in the company, valued at approximately $3,097,114.60. This trade represents a 1.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

SI-BONE Stock Up 1.8 %

Shares of SI-BONE stock opened at $14.40 on Thursday. SI-BONE, Inc. has a 1 year low of $11.70 and a 1 year high of $21.64. The company has a debt-to-equity ratio of 0.22, a current ratio of 8.25 and a quick ratio of 7.22. The company has a market capitalization of $603.91 million, a P/E ratio of -15.65 and a beta of 1.16. The business has a 50-day moving average of $13.66 and a two-hundred day moving average of $14.17.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on SIBN shares. Needham & Company LLC restated a “buy” rating and set a $19.00 price target on shares of SI-BONE in a research report on Wednesday, November 20th. Truist Financial raised their price target on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $23.00.

Institutional Trading of SI-BONE

A number of large investors have recently bought and sold shares of SIBN. Jane Street Group LLC raised its holdings in shares of SI-BONE by 29.0% during the third quarter. Jane Street Group LLC now owns 77,359 shares of the company’s stock worth $1,081,000 after acquiring an additional 17,410 shares during the period. Millrace Asset Group Inc. acquired a new position in SI-BONE in the 3rd quarter worth $1,056,000. Champlain Investment Partners LLC increased its holdings in SI-BONE by 14.7% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,800,073 shares of the company’s stock worth $39,145,000 after purchasing an additional 358,821 shares in the last quarter. Impax Asset Management Group plc raised its stake in shares of SI-BONE by 41.3% in the 3rd quarter. Impax Asset Management Group plc now owns 758,521 shares of the company’s stock valued at $10,604,000 after purchasing an additional 221,604 shares during the period. Finally, American Century Companies Inc. lifted its holdings in shares of SI-BONE by 22.8% in the second quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock valued at $25,685,000 after purchasing an additional 368,637 shares in the last quarter. 98.11% of the stock is owned by institutional investors.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.